EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311 | +14.3% | 60 | 0.0% | 0.00% | – |
| Q2 2023 | $1,147 | -1.5% | 60 | 0.0% | 0.00% | – |
| Q1 2023 | $1,165 | +21.1% | 60 | 0.0% | 0.00% | – |
| Q4 2022 | $962 | -3.8% | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 60 | +53.8% | 0.00% | – |
| Q3 2020 | $1,000 | -97.4% | 39 | -99.6% | 0.00% | -100.0% |
| Q1 2014 | $39,000 | -41.8% | 11,000 | 0.0% | 0.01% | -46.7% |
| Q4 2013 | $67,000 | +4.7% | 11,000 | 0.0% | 0.02% | -11.8% |
| Q3 2013 | $64,000 | +28.0% | 11,000 | 0.0% | 0.02% | +30.8% |
| Q2 2013 | $50,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |